Literature DB >> 17113189

Dermoscopy features of melanoma incognito: indications for biopsy.

Giuseppe Argenziano1, Iris Zalaudek, Gerardo Ferrara, Robert Johr, David Langford, Susana Puig, H Peter Soyer, Josep Malvehy.   

Abstract

BACKGROUND: To avoid missing melanoma, the current practice is to biopsy all suggestive skin lesions. Although most cases of melanoma exhibit clinical clues leading to the correct diagnosis, melanoma can mimic benign lesions. Dermoscopy has been shown to increase the diagnostic accuracy of clinically equivocal lesions, but little is known about its ability to detect melanoma in the context of lesions that appear clinically benign.
METHODS: We present 7 difficult-to-diagnose melanomas, in which additional clues provided by dermoscopy increased the index of suggestion and led us to perform a biopsy.
RESULTS: Our cases highlight the following 7 management rules: 1) Dermoscopy should not be used only for suggestive skin lesions. 2) Biopsy lesions missing clinicodermoscopic correlation. 3) Biopsy lesions with unspecific pigment pattern. 4) Biopsy lesions with spitzoid features. 5) Biopsy lesions with extensive regression features. 6) In patients with multiple nevi, biopsy lesions changing after short-term follow-up. 7) Biopsy pink lesions with an atypical vascular pattern. LIMITATIONS: The reported series of cases is small. Dermoscopy has not been rigorously compared with handheld magnification (as with a x7 loupe).
CONCLUSIONS: Dermoscopy can increase the index of suggestion to perform biopsy in difficult-to-diagnose melanomas.

Entities:  

Mesh:

Year:  2006        PMID: 17113189     DOI: 10.1016/j.jaad.2006.10.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

Review 1.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

2.  Photoacoustic discrimination of vascular and pigmented lesions using classical and Bayesian methods.

Authors:  Jennifer A Swearingen; Scott H Holan; Mary M Feldman; John A Viator
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

3.  Grey-blue regression in melanoma in situ-evaluation on 111 cases.

Authors:  S Bassoli; S Borsari; C Ferrari; F Giusti; G Pellacani; G Ponti; S Seidenari
Journal:  J Skin Cancer       Date:  2011-03-23

Review 4.  Vascular structures in dermoscopy.

Authors:  Erhan Ayhan; Derya Ucmak; ZeynepMeltem Akkurt
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

5.  Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients.

Authors:  Giulia Ciccarese; Bruna Dalmasso; William Bruno; Paola Queirolo; Lorenza Pastorino; Virginia Andreotti; Francesco Spagnolo; Enrica Tanda; Giovanni Ponti; Cesare Massone; Francesco Drago; Aurora Parodi; Giovanni Ghigliotti; Maria Antonietta Pizzichetta; Paola Ghiorzo
Journal:  J Transl Med       Date:  2020-02-13       Impact factor: 5.531

6.  An Updated Algorithm Integrated With Patient Data for the Differentiation of Atypical Nevi From Early Melanomas: the idScore 2021.

Authors:  Linda Tognetti; Alessandra Cartocci; Martina Bertello; Mafalda Giordani; Elisa Cinotti; Gabriele Cevenini; Pietro Rubegni
Journal:  Dermatol Pract Concept       Date:  2022-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.